Call for Experts 2025/July/213: Establishment of the Strategic Advisory Group on Prevention and Control of Noncommunicable disease of the WHO South-East Asia Region

The World Health Organization (WHO) is seeking experts to serve as members one of the Strategic Advisory Group on Prevention and Control of Noncommunicable disease . This “Call for experts” provides information about the advisory group in question, the expert profiles being sought, the process to express interest, and the process of selection.

 Background

Noncommunicable diseases (NCDs) pose a significant health and economic burden in the WHO South-East Asia (SE) Region, accounting for 55% of all deaths, with half occurring prematurely between ages 30-69. The four major NCDs—cardiovascular diseases, cancers, chronic respiratory diseases, and diabetes—make up 83% of NCD-related deaths, driven by risk factors such as tobacco  and areca nut use, unhealthy diets, physical inactivity, and alcohol consumption.  The latest estimates of World Health Statistics 2024, shows the Sustainable Development Goal 3.4.1 indicator on  probability of death from the four major NCDs among those aged between 30 and 70 years is still unacceptably high in the SE Asia Region and the progress stagnated from 2000 to 2019. The Implementation Roadmap for accelerating the prevention and control of NCDs in South-East Asia 2022–2030, along with WHO technical packages to address the risk factors, guide the Member States provides strategic directions on prevention and control of NCDs with  Member States  demonstrating sustained, high-level commitment to addressing the rising burden.

Against this backdrop, WHO SE Asia regional office is planning to formulate a Strategic Advisory Group (AG) o Prevention and Control of NCDs to act as an advisory body to WHO in this field.Against this backdrop, WHO SE Asia regional office is planning to formulate a Strategic Advisory Group (AG) on Prevention and Control of NCDs to act as an advisory body to WHO in this field.

Functions of the Strategic Advisory Group on  Prevention and Control of Noncommunicable disease

In its capacity as an advisory body to WHO, the AG shall have the following functions:

1. To provide independent evaluation of the scientific technical and strategic aspects of context specific issues related to scaling up services for NCD management in the region;
2. To provide independent evaluation of the scientific technical and strategic aspects of context specific measures in implementing the WHO technical packages on controlling  NCD risk factors;
3. To advise WHO on strategies to  overcome the challenges of implementing WHO technical packages for control  NCD risk factors in the context of SE Asia region;
4. To advise WHO on strategies to support the Member States to scale up the  NCD services  through evidence in the context of SE Asia region;
5. To advise WHO SEARO on strengthening of NCD and risk factors surveillance in SE Asia region

Operations of the Strategic Advisory Group on  Prevention and Control of Noncommunicable disease

The AG shall normally meet at least once each year. However, WHO may convene additional meetings.  AG meetings may be held in person (at a location determined by WHO) or virtually, via video or teleconference.

 AG meetings may be held in open and/or closed session, as decided by the Chairperson in consultation with WHO.

• Open sessions: Open sessions shall be convened for the sole purpose of the exchange of non-confidential information and views, and may be attended by Observers (as defined in paragraph III.3 below).
• Closed sessions: The sessions dealing with the formulation of recommendations and/or advice to WHO shall be restricted to the members of the AG and essential WHO Secretariat staff.

The quorum for AG meetings shall be two thirds of the members.

WHO may, at its sole discretion, invite external individuals from time to time to attend the open sessions of an advisory group, or parts thereof, as “observers”. Observers may be invited either in their personal capacity, or as representatives from a governmental institution / intergovernmental organization, or from a non-State actor. WHO will request observers invited in their personal capacity to complete a confidentiality undertaking and a declaration of interests form prior to attending a session of the advisory group.  Invitations to observers attending as representatives from non-State actors will be subject to WHO internal due diligence and risk assessment including conflict of interest considerations in accordance with the Framework for engagement with non-State actors (FENSA). Observers invited as representatives may also be requested to complete a confidentiality undertaking. Observers shall normally attend meetings of the AG at their own expense and be responsible for making all arrangements in that regard.

 At the invitation of the Chairperson, observers may be asked to present their personal views and/or the policies of their organization. Observers will not participate in the process of adopting recommendations of the AG.

 The AG may decide to establish smaller working groups (sub-groups of the AG) to work on specific issues. Their deliberations shall take place via teleconference or video-conference. For these sub-groups, no quorum requirement will apply; the outcome of their deliberations will be submitted to the AG for review at one of its meetings. 

 AG members are expected to attend meetings. If a member misses two consecutive meetings, WHO may end his/her appointment as a member of the AG. 

 Reports of each meeting shall be submitted by the AG to WHO (Director, Dept. of Healthier Population and NCDs). All recommendations from the AG are advisory to WHO, who retains full control over any subsequent decisions or actions regarding any proposals, policy issues or other matters considered by the AG.

 The AG shall normally make recommendations by consensus. If, in exceptional circumstances, a consensus on a particular issue cannot be reached, minority opinions will be reflected in the meeting report.

 Active participation is expected from all AG members, including in working groups, teleconferences, and interaction over email. AG members may, in advance of AG meetings, be requested to review meeting materials and to provide their views for consideration by the AG.

WHO shall determine the modes of communication by the AG, including between WHO and the AG members, and the AG members among themselves.

 AG members shall not speak on behalf of, or represent, the AG or WHO to any third party.

Who can express interest?

The Strategic Advisory Group on  Prevention and Control of Noncommunicable disease will be multidisciplinary, with members who have a range of technical knowledge, skills and experience relevant to Prevention and Control of Noncommunicable disease. Approximately 15 may be selected.

WHO welcomes expressions of interest from:
Public health professionals, Scientists, clinicians, researchers and healthcare regulators with expertise the following areas:

• Programme planning and management
• control of tobacco and areca nut use, unhealthy diets, physical inactivity, and alcohol consumption;
• control of commercial determinants of health
• management of cardiovascular diseases, cancers, chronic respiratory diseases, and diabetes;
• surveillance of NCDs

Submitting your expression of interest

To register your interest in being considered for the Strategic Advisory Group on  Prevention and Control of Noncommunicable disease, please submit the following documents by 29 August 2025  20:00Hrs (Indian Standard Time) to gunawardenan@who.int using the subject line “Expression of interest for the Strategic Advisory Group on  Prevention and Control of Noncommunicable disease”:

• A cover letter, indicating your motivation to apply and how you satisfy the selection criteria. Please note that, if selected, membership will be in a personal capacity. Therefore, do not use the letterhead or other identification of your employer);
• Your curriculum vitae; and
• A signed and completed Declaration of Interests (DOI) form for WHO Experts, available at https://www.who.int/about/ethics/declarations-of-interest.

After submission, your expression of interest will be reviewed by WHO.  Due to an expected high volume of interest, only selected individuals will be informed. 

Important information about the selection processes and conditions of appointment

Members of WHO AGs must be free of any real, potential or apparent conflicts of interest. To this end, applicants are required to complete the WHO Declaration of Interests for WHO Experts, and the selection as a member of a AG is, amongst other things, dependent on WHO determining that there is no conflict of interest or that any identified conflicts could be appropriately managed (in addition to WHO’s evaluation of an applicant’s experience, expertise and motivation and other criteria).

All AG members will serve in their individual expert capacity and shall not represent any governments, any commercial industries or entities, any research, academic or civil society organizations, or any other bodies, entities, institutions or organizations. They are expected to fully comply with the Code of Conduct for WHO Experts (https://www.who.int/about/ethics/declarations-of-interest). AG members will be expected to sign and return a completed confidentiality undertaking prior to the beginning of the first meeting.

 At any point during the selection process, telephone interviews may be scheduled between an applicant and the WHO Secretariat to enable WHO to ask questions relating to the applicant’s experience and expertise and/or  to assess whether the applicant meets the criteria for membership in the relevant AG.

The selection of members of the AGs will be made by WHO in its sole discretion, taking into account  the following (non-exclusive) criteria: relevant technical expertise; experience in international and country policy work; communication skills; and ability to work constructively with people from different cultural backgrounds and orientations .The selection of AG members will also take account of the need for diverse perspectives from different regions, especially from low and middle-income countries, and for gender balance.

If selected by WHO, proposed members will be sent an invitation letter and a Memorandum of Agreement. Appointment as a member of a AG will be subject to the proposed member returning to WHO the countersigned copy of these two documents.

WHO reserves the right to accept or reject any expression of interest , to annul the open call process and reject all expressions of interest at any time without incurring any liability to the affected applicant or applicants and without any obligation to inform the affected applicant or applicants of the grounds for WHO’s action. WHO may also decide, at any time, not to proceed with the establishment of the AG, disband an existing TAG or modify the work of the AG.

WHO shall not in any way be obliged to reveal, or discuss with any applicant, how an expression of interest was assessed, or to provide any other information relating to the evaluation/selection process or to state the reasons for not choosing a member.

WHO may publish the names and a short biography of the selected individuals on the WHO internet.

AG members will not be remunerated for their services in relation to the AG or otherwise. Travel and accommodation expenses of AG members to participate in AG meetings will be covered by WHO in accordance with its applicable policies, rules and procedures.

The appointment will be limited in time as indicated in the letter of appointment.

If you have any questions about this “Call for experts”, please write to gunawardenan@who.int well before the applicable deadline. 

Related Documents: Terms of Referance AG on NCDs

Deadline: 29 August 2025

Official announcement: WHO SEARO

⚡ Looking for expert analysis, policy briefs, and high-level reviews on Nepal's health sector?

We are now offering premium subscription services to deliver timely, evidence-backed policy briefs, comprehensive technical reviews, and strategic analysis straight to your inbox. Tap into specialized consultant expertise and stay ahead on Nepal's emerging health strategies.

👉 [Contact Us]